Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Gilead call volume above normal and directionally bullish » 14:25
06/16/21
06/16
14:25
06/16/21
14:25
GILD

Gilead

$67.68 /

-0.43 (-0.63%)

Bullish option flow…

Bullish option flow detected in Gilead with 15,976 calls trading, 1.1x expected, and implied vol increasing over 1 point to 20.42%. Jun-21 70 calls and Jul-21 70 calls are the most active options, with total volume in those strikes near 7,000 contracts. The Put/Call Ratio is 0.24. Earnings are expected on July 29th.

ShowHide Related Items >><<
GILD Gilead
$67.68 /

-0.43 (-0.63%)

GILD Gilead
$67.68 /

-0.43 (-0.63%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
GILD Gilead
$67.68 /

-0.43 (-0.63%)

GILD Gilead
$67.68 /

-0.43 (-0.63%)

GILD Gilead
$67.68 /

-0.43 (-0.63%)

GILD Gilead
$67.68 /

-0.43 (-0.63%)

Recommendations
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital » 13:58
06/16/21
06/16
13:58
06/16/21
13:58
JNCE

Jounce Therapeutics

$7.41 /

-0.11 (-1.46%)

, GILD

Gilead

$68.57 /

+0.46 (+0.68%)

Roth Capital analyst…

Roth Capital analyst Zegbeh Jallah notes that Jounce Therapeutics (JNCE) announced IND-clearance for JTX-1811, its CCR8 antibody licensed to Gilead (GILD), and per the agreement, this milestone triggers a $25M payment to Jounce. Gilead will now also assume all future development associated with the program, and Jounce is eligible to receive an additional $660M in milestone payments plus royalties. The analyst believes that JTX-1811 has significant potential in immuno-oncology, further validating Jounce's immunooncology platform, and looks forward to hearing more at the company's Virtual R&D day on June 23rd. Jallah has a Buy rating and a price target of $15 on Jounce's shares.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.41 /

-0.11 (-1.46%)

GILD Gilead
$68.57 /

+0.46 (+0.68%)

JNCE Jounce Therapeutics
$7.41 /

-0.11 (-1.46%)

06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
GILD Gilead
$68.57 /

+0.46 (+0.68%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
JNCE Jounce Therapeutics
$7.41 /

-0.11 (-1.46%)

GILD Gilead
$68.57 /

+0.46 (+0.68%)

  • 10
    Mar
GILD Gilead
$68.57 /

+0.46 (+0.68%)

JNCE Jounce Therapeutics
$7.41 /

-0.11 (-1.46%)

GILD Gilead
$68.57 /

+0.46 (+0.68%)

GILD Gilead
$68.57 /

+0.46 (+0.68%)

Tuesday
On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:25
06/15/21
06/15
16:25
06/15/21
16:25
BA

Boeing

$246.55 /

+1.48 (+0.60%)

, EADSY

Airbus

$34.33 /

+0.32 (+0.94%)

, NVAX

Novavax

$187.15 /

-21.05 (-10.11%)

, AZN

AstraZeneca

$58.84 /

+0.09 (+0.15%)

, AAPL

Apple

$129.75 /

-0.74 (-0.57%)

, GOOG

Alphabet

$2,520.68 /

-6.19 (-0.24%)

, GOOGL

Alphabet Class A

$2,428.41 /

-16.59 (-0.68%)

, NTDOY

Nintendo

$73.23 /

-1.05 (-1.41%)

, WPC

W.P. Carey

$77.61 /

-0.03 (-0.04%)

, CR

Crane

$91.81 /

+0.995 (+1.10%)

, ACRS

Aclaris Therapeutics

$17.73 /

-0.005 (-0.03%)

, CDAY

Ceridian

$84.54 /

-4.64 (-5.20%)

, FAST

Fastenal

$51.54 /

-1.19 (-2.26%)

, AMZN

Amazon.com

$3,381.76 /

-0.86 (-0.03%)

, DKNG

DraftKings

$48.51 /

-2.115 (-4.18%)

, DISH

Dish

$40.16 /

+0.135 (+0.34%)

, MSFT

Microsoft

$258.65 /

-1.3 (-0.50%)

, NFLX

Netflix

$492.17 /

-7.43 (-1.49%)

, OCGN

Ocugen

$6.28 /

+0.13 (+2.11%)

, ELAN

Elanco

$34.83 /

+1.33 (+3.97%)

, FOA

Finance of America

$8.85 /

+1.55 (+21.23%)

, SAGE

Sage Therapeutics

$59.00 /

-13.88 (-19.05%)

, VRM

Vroom

$40.01 /

-5.125 (-11.36%)

, SAVE

Spirit Airlines

$33.99 /

+0.035 (+0.10%)

, QD

Qudian

$2.39 /

-0.05 (-2.05%)

, BCOR

Blucora

$18.34 /

+1.37 (+8.07%)

, HLIO

Helios Technologies

$73.85 /

+1.88 (+2.61%)

, BBCP

Concrete Pumping

$8.43 /

-0.11 (-1.29%)

Get caught up quickly on…

ShowHide Related Items >><<
WPC W.P. Carey
$77.61 /

-0.03 (-0.04%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

SAGE Sage Therapeutics
$59.00 /

-13.88 (-19.05%)

QD Qudian
$2.39 /

-0.05 (-2.05%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FOA Finance of America
$8.85 /

+1.55 (+21.23%)

FAST Fastenal
$51.54 /

-1.19 (-2.26%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

EADSY Airbus
$34.33 /

+0.32 (+0.94%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

BCOR Blucora
$18.34 /

+1.37 (+8.07%)

BBCP Concrete Pumping
$8.43 /

-0.11 (-1.29%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

06/15/21 Berenberg
Boeing price target raised to $245 from $215 at Berenberg
06/10/21 Jefferies
Boeing shares could move up 5% on China recertification, says Jefferies
06/09/21 Susquehanna
Boeing estimates lowered on light May deliveries, says Susquehanna
06/03/21 Morgan Stanley
Morgan Stanley says recovery tailwinds can offset new launch headwinds at Boeing
EADSY Airbus
$34.33 /

+0.32 (+0.94%)

06/15/21 Berenberg
Airbus price target raised to EUR 140 from EUR 110 at Berenberg
06/11/21 Credit Suisse
Airbus assumed with an Outperform at Credit Suisse
06/02/21 Barclays
Airbus price target raised to EUR 138 from EUR 113 at Barclays
06/02/21
Fly Intel: Top five analyst upgrades
NVAX Novavax
$187.15 /

-21.05 (-10.11%)

06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AAPL Apple
$129.75 /

-0.74 (-0.57%)

06/11/21 Argus
Apple underperformance due to sector rotation, not misfires, says Argus
06/08/21 RBC Capital
Fisker initiated with an Outperform at RBC Capital
06/08/21 BofA
Apple App store growth decelerating in Q3 to-date, says BofA
06/08/21 Wedbush
Apple WWDC 'all about iOS 15, new Macs,' says Wedbush
GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

06/16/21 Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/11/21 Tigress Financial
Tigress sees Alphabet shares rising to $3,185 in 12 months
06/02/21 KGI Securities
Alphabet initiated with an Outperform at KGI Securities
05/19/21 JPMorgan
Broadcom continues to win AI chip work at Google, says JPMorgan
GOOGL Alphabet Class A
$2,428.41 /

-16.59 (-0.68%)

06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

05/21/21 Citi
Nintendo downgraded to Neutral from Buy at Citi
11/06/20 DZ Bank
Nintendo upgraded to Buy from Sell at DZ Bank
09/10/20 Jefferies
Nintendo upgraded to Buy on WFH boost at Jefferies
09/10/20 Jefferies
Nintendo upgraded to Buy from Hold at Jefferies
WPC W.P. Carey
$77.61 /

-0.03 (-0.04%)

06/15/21
Fly Intel: Top five analyst upgrades
06/15/21 JPMorgan
JPMorgan upgrades W.P. Carey on swap out of Broadstone
06/15/21 JPMorgan
W.P. Carey upgraded to Overweight from Neutral at JPMorgan
05/03/21 Evercore ISI
W.P. Carey upgraded to Outperform at Evercore ISI on accelerating acquisitions
CR Crane
$91.81 /

+0.995 (+1.10%)

06/15/21 DA Davidson
Crane upgraded to Buy at DA Davidson following Engineered Materials divestment
06/15/21 DA Davidson
Crane upgraded to Buy from Neutral at DA Davidson
05/05/21 DA Davidson
Crane price target raised to $105 from $85 at DA Davidson
ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

06/16/21 H.C. Wainwright
Aclaris Therapeutics price target raised to $50 from $40 at H.C. Wainwright
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Piper Sandler
Aclaris Therapeutics initiated with an Overweight at Piper Sandler
04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Needham
Ceridian downgraded to Hold from Buy at Needham
05/28/21 Jefferies
Ceridian price target lowered to $95 from $110 at Jefferies
05/06/21 Mizuho
Ceridian price target raised to $120 from $110 at Mizuho
FAST Fastenal
$51.54 /

-1.19 (-2.26%)

06/15/21 Morgan Stanley
Fastenal downgraded to Underweight from Equal Weight at Morgan Stanley
06/04/21 Raymond James
Fastenal's May ADS down 3.2% off challenging comparison, says Raymond James
05/03/21 Raymond James
Grainger price target raised to $460 from $400 at Raymond James
AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

06/16/21 JPMorgan
JPMorgan values Amazon Prime at $1,000 per year, 8.5 times actual price
06/16/21 Pivotal Research
Dish upgraded to Buy from Hold at Pivotal Research
06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

06/16/21 Susquehanna
DraftKings report referenced allegations prior to acquisition, says Susquehanna
06/16/21 Morgan Stanley
Morgan Stanley says DraftKings opportunity around core U.S. business, not SBTech
06/15/21 Credit Suisse
DraftKings selloff on short report overdone, says Credit Suisse
06/02/21 Morgan Stanley
DraftKings price target lowered to $58 from $63 at Morgan Stanley
DISH Dish
$40.16 /

+0.135 (+0.34%)

06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
06/09/21 JPMorgan
Dish downgraded to Underweight from Neutral at JPMorgan
MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
06/01/21 KGI Securities
Microsoft initiated with an Outperform at KGI Securities
NFLX Netflix
$492.17 /

-7.43 (-1.49%)

06/16/21 JPMorgan
JPMorgan 'incrementally positive' on Netflix into second half content slate
06/01/21 KGI Securities
Netflix initiated with a Neutral at KGI Securities
05/27/21 Stifel
Stifel sees 'minimal impact' to Netflix from Amazon's MGM acquisition
05/27/21 Benchmark
Streaming field 'looking ever less unipolar around Netflix,' says Benchmark
OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
06/10/21 Roth Capital
Ocugen downgraded to Neutral from Buy at Roth Capital
06/10/21 Chardan
Ocugen price target lowered to $4.50 from $8 at Chardan
ELAN Elanco
$34.83 /

+1.33 (+3.97%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
FOA Finance of America
$8.85 /

+1.55 (+21.23%)

06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
SAGE Sage Therapeutics
$59.00 /

-13.88 (-19.05%)

06/16/21 William Blair
Sage Therapeutics downgraded to Market Perform from Outperform at William Blair
06/16/21 BMO Capital
Sage Therapeutics price target lowered to $73 from $87 at BMO Capital
06/16/21 Citi
Sage Therapeutics downgraded to Neutral from Buy at Citi
06/15/21 Piper Sandler
Street 'unfairly penalizing' Sage depression drug, says Piper Sandler
VRM Vroom
$40.01 /

-5.125 (-11.36%)

05/13/21 Raymond James
Vroom price target raised to $53 from $47 at Raymond James
05/13/21 JMP Securities
Vroom price target raised to $55 from $48 at JMP Securities
05/13/21 Piper Sandler
Vroom price target lowered to $58 from $60 at Piper Sandler
04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

06/15/21 Citi
Spirit Airlines upgraded to Buy from Neutral at Citi
06/09/21 MKM Partners
MKM sees 'a lot to like' in Spirit Airlines' valuation
06/09/21 MKM Partners
Spirit Airlines initiated with a Buy at MKM Partners
QD Qudian
$2.39 /

-0.05 (-2.05%)

BCOR Blucora
$18.34 /

+1.37 (+8.07%)

04/01/21 JPMorgan
Blucora assumed with an Overweight at JPMorgan
02/17/21 Barrington
Blucora price target raised to $19 from $16 at Barrington
08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

06/15/21 Baird
Helios Technologies price target raised to $94 from $89 at Baird
05/11/21 Baird
Helios Technologies price target raised to $89 from $84 at Baird
05/11/21 Baird
Helios Technologies updated guidance above previous range, says Baird
03/02/21 Baird
Helios Technologies price target raised to $82 from $72 at Baird
BBCP Concrete Pumping
$8.43 /

-0.11 (-1.29%)

06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
01/13/21 B. Riley
Concrete Pumping price target lowered to $6 from $6.75 at B. Riley Securities
01/07/21 B. Riley
Concrete Pumping price target raised to $6.75 from $6.50 at B. Riley Securities
WPC W.P. Carey
$77.61 /

-0.03 (-0.04%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

SAGE Sage Therapeutics
$59.00 /

-13.88 (-19.05%)

QD Qudian
$2.39 /

-0.05 (-2.05%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FAST Fastenal
$51.54 /

-1.19 (-2.26%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

EADSY Airbus
$34.33 /

+0.32 (+0.94%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

BCOR Blucora
$18.34 /

+1.37 (+8.07%)

BBCP Concrete Pumping
$8.43 /

-0.11 (-1.29%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

  • 10
    Jun
  • 08
    Jun
  • 20
    Jan
  • 07
    Dec
  • 01
    Dec
  • 19
    Nov
  • 07
    Oct
  • 11
    Sep
  • 26
    Aug
  • 18
    Jun
  • 19
    Jun
VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

EADSY Airbus
$34.33 /

+0.32 (+0.94%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FAST Fastenal
$51.54 /

-1.19 (-2.26%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

QD Qudian
$2.39 /

-0.05 (-2.05%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

GOOGL Alphabet Class A
$2,428.41 /

-16.59 (-0.68%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FOA Finance of America
$8.85 /

+1.55 (+21.23%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

Recommendations
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler » 12:22
06/15/21
06/15
12:22
06/15/21
12:22
JNCE

Jounce Therapeutics

$7.84 /

+0.87 (+12.48%)

, GILD

Gilead

$67.89 /

-0.26 (-0.38%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff reiterates an Overweight rating and $20 price target on Jounce Therapeutics (JNCE), which will receive a $25M milestone from partner Gilead (GILD) for IND clearance for anti-CCR8 antibody GS-1811. Jounce, which expects to initiate eight expansion cohorts in 2H21, now holds pro forma cash of roughly $296M to advance its innovative I-O pipeline, Tenthoff tells investors in a research note.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
GILD Gilead
$67.89 /

-0.26 (-0.38%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

  • 10
    Mar
GILD Gilead
$67.89 /

-0.26 (-0.38%)

JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:06
06/15/21
06/15
12:06
06/15/21
12:06
BA

Boeing

$245.71 /

+0.64 (+0.26%)

, EADSY

Airbus

$34.01 /

-0.02 (-0.06%)

, NVAX

Novavax

$189.20 /

-19 (-9.13%)

, AZN

AstraZeneca

$58.62 /

-0.13 (-0.22%)

, CLSD

Clearside Biomedical

$3.84 /

+0.8 (+26.32%)

, DCRC

Decarbonization Plus Acquisition III

$10.72 /

-1.31 (-10.89%)

, WPC

W.P. Carey

$77.50 /

-0.14 (-0.18%)

, CR

Crane

$91.42 /

+0.61 (+0.67%)

, ACRS

Aclaris Therapeutics

$17.59 /

-0.14 (-0.79%)

, CDAY

Ceridian

$85.53 /

-3.65 (-4.09%)

, FAST

Fastenal

$51.70 /

-1.03 (-1.95%)

, AMZN

Amazon.com

$3,371.43 /

-11.19 (-0.33%)

, DKNG

DraftKings

$48.28 /

-2.34 (-4.62%)

, DISH

Dish

$39.69 /

-0.335 (-0.84%)

, MSFT

Microsoft

$259.24 /

-0.71 (-0.27%)

, NFLX

Netflix

$494.25 /

-5.35 (-1.07%)

, OCGN

Ocugen

$6.59 /

+0.44 (+7.15%)

, ELAN

Elanco

$35.23 /

+1.73 (+5.16%)

, FOA

Finance of America

$8.83 /

+1.53 (+20.96%)

, SAGE

Sage Therapeutics

$60.33 /

-12.55 (-17.22%)

, VRM

Vroom

$40.55 /

-4.58 (-10.15%)

, SAVE

Spirit Airlines

$33.83 /

-0.125 (-0.37%)

, QD

Qudian

$2.25 /

-0.19 (-7.79%)

, BCOR

Blucora

$18.37 /

+1.4 (+8.25%)

, HLIO

Helios Technologies

$72.61 /

+0.64 (+0.89%)

, BBCP

Concrete Pumping

$8.44 /

-0.1 (-1.17%)

Get caught up quickly on…

ShowHide Related Items >><<
WPC W.P. Carey
$77.50 /

-0.14 (-0.18%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

SAGE Sage Therapeutics
$60.33 /

-12.55 (-17.22%)

QD Qudian
$2.25 /

-0.19 (-7.79%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

FOA Finance of America
$8.83 /

+1.53 (+20.96%)

FAST Fastenal
$51.70 /

-1.03 (-1.95%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

EADSY Airbus
$34.01 /

-0.02 (-0.06%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

CR Crane
$91.42 /

+0.61 (+0.67%)

CLSD Clearside Biomedical
$3.84 /

+0.8 (+26.32%)

CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

BCOR Blucora
$18.37 /

+1.4 (+8.25%)

BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

06/15/21 Berenberg
Boeing price target raised to $245 from $215 at Berenberg
06/10/21 Jefferies
Boeing shares could move up 5% on China recertification, says Jefferies
06/09/21 Susquehanna
Boeing estimates lowered on light May deliveries, says Susquehanna
06/03/21 Morgan Stanley
Morgan Stanley says recovery tailwinds can offset new launch headwinds at Boeing
EADSY Airbus
$34.01 /

-0.02 (-0.06%)

06/15/21 Berenberg
Airbus price target raised to EUR 140 from EUR 110 at Berenberg
06/11/21 Credit Suisse
Airbus assumed with an Outperform at Credit Suisse
06/02/21 Barclays
Airbus price target raised to EUR 138 from EUR 113 at Barclays
06/02/21
Fly Intel: Top five analyst upgrades
NVAX Novavax
$189.20 /

-19 (-9.13%)

06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
CLSD Clearside Biomedical
$3.84 /

+0.8 (+26.32%)

06/15/21 Roth Capital
Clearside reported 'impressive' data in wet AMD, says Roth Capital
06/02/21 Roth Capital
Clearside success with Xipere can derisk pipeline, says Roth Capital
05/18/21 Roth Capital
Clearside Biomedical price target raised to $9 from $8 at Roth Capital
03/02/21 Roth Capital
Clearside enrollment speed 'encouraging,' says Roth Capital
DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

WPC W.P. Carey
$77.50 /

-0.14 (-0.18%)

06/15/21
Fly Intel: Top five analyst upgrades
06/15/21 JPMorgan
JPMorgan upgrades W.P. Carey on swap out of Broadstone
06/15/21 JPMorgan
W.P. Carey upgraded to Overweight from Neutral at JPMorgan
05/03/21 Evercore ISI
W.P. Carey upgraded to Outperform at Evercore ISI on accelerating acquisitions
CR Crane
$91.42 /

+0.61 (+0.67%)

06/15/21 DA Davidson
Crane upgraded to Buy at DA Davidson following Engineered Materials divestment
06/15/21 DA Davidson
Crane upgraded to Buy from Neutral at DA Davidson
05/05/21 DA Davidson
Crane price target raised to $105 from $85 at DA Davidson
ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Piper Sandler
Aclaris Therapeutics initiated with an Overweight at Piper Sandler
04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
03/04/21 SVB Leerink
Aclaris Therapeutics price target raised to $26 from $21 at SVB Leerink
CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Needham
Ceridian downgraded to Hold from Buy at Needham
05/28/21 Jefferies
Ceridian price target lowered to $95 from $110 at Jefferies
05/06/21 Mizuho
Ceridian price target raised to $120 from $110 at Mizuho
FAST Fastenal
$51.70 /

-1.03 (-1.95%)

06/15/21 Morgan Stanley
Fastenal downgraded to Underweight from Equal Weight at Morgan Stanley
06/04/21 Raymond James
Fastenal's May ADS down 3.2% off challenging comparison, says Raymond James
05/03/21 Raymond James
Grainger price target raised to $460 from $400 at Raymond James
AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Piper Sandler
New Amazon offering targets Hims & Hers and others, says Piper Sandler
06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

06/15/21 Credit Suisse
DraftKings selloff on short report overdone, says Credit Suisse
06/02/21 Morgan Stanley
DraftKings price target lowered to $58 from $63 at Morgan Stanley
05/24/21 Argus
DraftKings price target lowered to $60 from $78 at Argus
05/12/21
Fly Intel: Top five analyst upgrades
DISH Dish
$39.69 /

-0.335 (-0.84%)

06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
06/09/21 JPMorgan
Dish downgraded to Underweight from Neutral at JPMorgan
05/24/21 HSBC
Dish price target raised to $40 from $26 at HSBC
MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
06/01/21 KGI Securities
Microsoft initiated with an Outperform at KGI Securities
NFLX Netflix
$494.25 /

-5.35 (-1.07%)

06/01/21 KGI Securities
Netflix initiated with a Neutral at KGI Securities
05/27/21 Stifel
Stifel sees 'minimal impact' to Netflix from Amazon's MGM acquisition
05/27/21 Benchmark
Streaming field 'looking ever less unipolar around Netflix,' says Benchmark
05/26/21 Piper Sandler
Amazon deal to buy MGM Studios 'looks sensible,' says Piper Sandler
OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
06/10/21 Roth Capital
Ocugen downgraded to Neutral from Buy at Roth Capital
06/10/21 Chardan
Ocugen price target lowered to $4.50 from $8 at Chardan
ELAN Elanco
$35.23 /

+1.73 (+5.16%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
FOA Finance of America
$8.83 /

+1.53 (+20.96%)

06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
SAGE Sage Therapeutics
$60.33 /

-12.55 (-17.22%)

06/15/21 Stifel
Sage, Biogen data support FDA approval in depression, says Stifel
06/15/21 Piper Sandler
Sage selloff on zuranolone data an overreaction, says Piper Sandler
05/05/21 Mizuho
Sage Therapeutics price target lowered to $77 from $81 at Mizuho
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
VRM Vroom
$40.55 /

-4.58 (-10.15%)

05/13/21 Raymond James
Vroom price target raised to $53 from $47 at Raymond James
05/13/21 JMP Securities
Vroom price target raised to $55 from $48 at JMP Securities
05/13/21 Piper Sandler
Vroom price target lowered to $58 from $60 at Piper Sandler
04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

06/15/21 Citi
Spirit Airlines upgraded to Buy from Neutral at Citi
06/09/21 MKM Partners
MKM sees 'a lot to like' in Spirit Airlines' valuation
06/09/21 MKM Partners
Spirit Airlines initiated with a Buy at MKM Partners
QD Qudian
$2.25 /

-0.19 (-7.79%)

06/16/20 China Renaissance
China Renaissance ups LexinFintech to Buy, raises Fintech sector to Overweight
BCOR Blucora
$18.37 /

+1.4 (+8.25%)

04/01/21 JPMorgan
Blucora assumed with an Overweight at JPMorgan
02/17/21 Barrington
Blucora price target raised to $19 from $16 at Barrington
08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

05/11/21 Baird
Helios Technologies price target raised to $89 from $84 at Baird
05/11/21 Baird
Helios Technologies updated guidance above previous range, says Baird
03/02/21 Baird
Helios Technologies price target raised to $82 from $72 at Baird
10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
01/13/21 B. Riley
Concrete Pumping price target lowered to $6 from $6.75 at B. Riley Securities
01/07/21 B. Riley
Concrete Pumping price target raised to $6.75 from $6.50 at B. Riley Securities
WPC W.P. Carey
$77.50 /

-0.14 (-0.18%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

SAGE Sage Therapeutics
$60.33 /

-12.55 (-17.22%)

QD Qudian
$2.25 /

-0.19 (-7.79%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

FAST Fastenal
$51.70 /

-1.03 (-1.95%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

EADSY Airbus
$34.01 /

-0.02 (-0.06%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

CR Crane
$91.42 /

+0.61 (+0.67%)

CLSD Clearside Biomedical
$3.84 /

+0.8 (+26.32%)

CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

BCOR Blucora
$18.37 /

+1.4 (+8.25%)

BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

  • 10
    Jun
  • 08
    Jun
  • 20
    Jan
  • 07
    Dec
  • 01
    Dec
  • 19
    Nov
  • 07
    Oct
  • 11
    Sep
  • 26
    Aug
  • 18
    Jun
  • 19
    Jun
VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

EADSY Airbus
$34.01 /

-0.02 (-0.06%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

CR Crane
$91.42 /

+0.61 (+0.67%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

FAST Fastenal
$51.70 /

-1.03 (-1.95%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

CR Crane
$91.42 /

+0.61 (+0.67%)

CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

QD Qudian
$2.25 /

-0.19 (-7.79%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

FOA Finance of America
$8.83 /

+1.53 (+20.96%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

Hot Stocks
Jounce Therapeutics achieves first milestone in license agreement with Gilead » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
JNCE

Jounce Therapeutics

$6.98 /

-0.07 (-0.99%)

, GILD

Gilead

$68.15 /

+0.09 (+0.13%)

Jounce Therapeutics…

Jounce Therapeutics (JNCE) announced the Food and Drug Administration's clearance of its Investigational New Drug application for JTX-1811, an anti-CCR8 antibody, for which Gilead Sciences (GILD) has exclusive rights to develop and commercialize. The IND clearance triggers a $25M milestone payment to Jounce. Under the terms of the September 2020 agreement, Gilead invested $35M in Jounce's common stock and made an $85M upfront payment to Jounce. Jounce has led the development of JTX-1811 through IND clearance, after which Gilead now has the sole right to develop and commercialize the program. After receiving this $25M milestone payment, Jounce may receive up to an additional $660M in future clinical, regulatory and commercial milestone payments and will also be eligible to receive royalties ranging from high single digit to mid-teens based upon worldwide sales. Any milestone or royalty paid to Jounce is subject to certain reductions as described in the license agreement.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
GILD Gilead
$68.15 /

+0.09 (+0.13%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

  • 10
    Mar
GILD Gilead
$68.15 /

+0.09 (+0.13%)

JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

Hot Stocks
AstraZeneca: Covid-19 vaccine effective against Delta variant » 06:07
06/15/21
06/15
06:07
06/15/21
06:07
AZN

AstraZeneca

$58.75 /

-0.02 (-0.03%)

New data from Public…

New data from Public Health England demonstrated COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant, AstraZeneca said in a statement. Real world data from PHE, published as a pre-print, demonstrated two doses of COVID-19 Vaccine AstraZeneca are 92% effective against hospitalization due to the Delta variant and showed no deaths among those vaccinated. The vaccine also showed a high level of effectiveness against the Alpha variant with an 86% reduction of hospitalizations and no deaths reported. The data suggest that vaccine effectiveness against milder symptomatic disease, although significant, was lower. Vaccine effectiveness against symptomatic disease was 74% against the Alpha variant and 64% against the Delta variant. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, said: "This real world evidence shows that COVID-19 Vaccine AstraZeneca provides a high level of protection against the Delta variant, which is currently a critical area of concern given its rapid transmission. The data show that the vaccine will continue to have a significant impact around the world given that it continues to account for the overwhelming majority of supplies to India and the COVAX facility." Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

Hot Stocks
AstraZeneca: Storm Chaser trial did not meet primary endpoint » 06:05
06/15/21
06/15
06:05
06/15/21
06:05
AZN

AstraZeneca

$58.75 /

-0.02 (-0.03%)

AstraZeneca announced…

AstraZeneca announced results from the STORM CHASER trial assessing the safety and efficacy of AZD7442, a long-acting antibody combination, for the prevention of symptomatic COVID-19 in participants recently exposed to the SARS-CoV-2 virus. The trial did not meet the primary endpoint of post-exposure prevention of symptomatic COVID-19 with AZD7442 compared to placebo. Trial participants were unvaccinated adults 18 years and over with confirmed exposure to a person with a case of the SARS-CoV-2 virus within the past eight days. In the overall trial population, AZD7442 reduced the risk of developing symptomatic COVID-19 by 33% compared to placebo, which was not statistically significant. Myron J. Levin, MD, Professor of Pediatrics and Medicine, University of Colorado School of Medicine, US, and principal investigator on the trial, said: "The results of STORM CHASER suggest that AZD7442 may be useful in preventing symptomatic COVID-19 in individuals not already infected. The PROVENT trial will give us more clarity in this patient population. While COVID-19 vaccination efforts have been successful, there is still a significant need for prevention and treatment options for certain populations, including those unable to be vaccinated or those who may have an inadequate response to vaccination." Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

AZN AstraZeneca
$58.75 /

-0.02 (-0.03%)

Monday
Hot Stocks
Pfizer vaccine 96% effective against hospitalization from Delta, PHE says » 13:08
06/14/21
06/14
13:08
06/14/21
13:08
PFE

Pfizer

$39.47 /

-0.68 (-1.69%)

, BNTX

BioNTech

$224.34 /

-13.95 (-5.85%)

, AZN

AstraZeneca

$58.58 /

-0.195 (-0.33%)

A new analysis by Public…

A new analysis by Public Health England shows for the first time that two doses of Covid-19 vaccines are highly effective against hospitalization from the Delta variant. The Pfizer (PFE) - BioNTech (BNTX) vaccine is 96% effective against hospitalization after two doses the Oxford-AstraZeneca (AZN) vaccine is 92% effective against hospitalization after two doses, the agency said in a statement. The analysis included 14,019 cases of the Delta variant - 166 of whom were hospitalized - between April 12 and June 4, looking at emergency hospital admissions in England. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$39.47 /

-0.68 (-1.69%)

BNTX BioNTech
$224.34 /

-13.95 (-5.85%)

AZN AstraZeneca
$58.58 /

-0.195 (-0.33%)

PFE Pfizer
$39.47 /

-0.68 (-1.69%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
BNTX BioNTech
$224.34 /

-13.95 (-5.85%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/11/21
Fly Intel: Top five analyst downgrades
AZN AstraZeneca
$58.58 /

-0.195 (-0.33%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
PFE Pfizer
$39.47 /

-0.68 (-1.69%)

BNTX BioNTech
$224.34 /

-13.95 (-5.85%)

AZN AstraZeneca
$58.58 /

-0.195 (-0.33%)

  • 23
    Jul
PFE Pfizer
$39.47 /

-0.68 (-1.69%)

BNTX BioNTech
$224.34 /

-13.95 (-5.85%)

AZN AstraZeneca
$58.58 /

-0.195 (-0.33%)

PFE Pfizer
$39.47 /

-0.68 (-1.69%)

BNTX BioNTech
$224.34 /

-13.95 (-5.85%)

AZN AstraZeneca
$58.58 /

-0.195 (-0.33%)

PFE Pfizer
$39.47 /

-0.68 (-1.69%)

BNTX BioNTech
$224.34 /

-13.95 (-5.85%)

AZN AstraZeneca
$58.58 /

-0.195 (-0.33%)

Sunday
Periodicals
EMA says AstraZeneca shots have good risk-benefit for over 60s, Reuters says » 18:01
06/13/21
06/13
18:01
06/13/21
18:01
AZN

AstraZeneca

$58.77 /

-0.08 (-0.14%)

The head of the EU drug…

The head of the EU drug regulator's COVID-19 task force said on Sunday that AstraZeneca's coronavirus vaccine had a favorable risk-benefit profile for all age groups and particularly for those aged over 60, according to Reuters. Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$58.77 /

-0.08 (-0.14%)

AZN AstraZeneca
$58.77 /

-0.08 (-0.14%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AZN AstraZeneca
$58.77 /

-0.08 (-0.14%)

AZN AstraZeneca
$58.77 /

-0.08 (-0.14%)

AZN AstraZeneca
$58.77 /

-0.08 (-0.14%)

AZN AstraZeneca
$58.77 /

-0.08 (-0.14%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.